Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Merck KGaA May Withdraw Research from Portugal over Debt-Report

07/09/2012 | 02:28am US/Eastern

German chemical company Merck KGaA (>> Merck KGaA) may withdraw future investments for research projects in Portugal worth tens of millions of euros unless the government hospitals stick to the agreed-upon debt repayments, German daily newspaper Financial Times Deutschland reports Monday.

Merck Portugal's manager Fritz Sacher told the paper the company's research projects are long-term and require mutual trust as a basis. "The Portuguese government's lacking payment habits undermine this trust," he is quoted as saying.

Portuguese government hospitals owe the pharmaceutical industry a total of more than 1.5 billion euros ($1.84 billion) and companies have to wait nearly 550 days on average until invoices are paid, FTD reports.

Some companies, including Roche Holding AG (ROG.VX), have already halted the sale of medications on credit to highly indebted countries like Portugal, Greece, Spain and Italy until outstanding debts are paid, the paper notes, but for many companies such drastic steps are difficult as they carry responsibility for people's wellbeing.

Withdrawing research projects is a way of putting pressure on the government, as Portugal is an attractive location for research investments, FTD says. "The conditions for certain research and human studies are as good as in the U.S., but it's significantly more cost-effective in Portugal," Sacher told the paper.

Newspaper website:

Write to the Frankfurt Bureau at

Stocks mentioned in the article : Merck KGaA
React to this article
Latest news on MERCK KGAA
01/20 MERCK KGAA : Presents Liquid Crystal Window Technology at BAU 2015
01/15 MERCK KGAA : Presents Liquid Crystal Window Technology at BAU 2015
01/14 MERCK KGAA : Positions itself with New Suprima® Quality Brand for High-Quality E..
01/08 MERCK KGAA : Researchers from Merck KGaA Detail Findings in Immunoglobulins (IgG..
01/06DJBerenberg, BayernLB to Join Forces in Investment Banking
01/06 MERCK KGAA : Silence Therapeutics Announces Board changes
2014 MERCK KGAA : Announces Resignation Of Claus-Dieter Boedecker
2014 MERCK KGAA : Researchers from Merck KGaA Provide Details of New Studies and Find..
2014 MERCK KGAA : Obtains US Antitrust Clearance for Acquisition of Sigma-Aldrich
2014 MERCK KGAA : Temecula reports strong job growth
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes